Charles Riv Lab Rg
CRL
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
02/28/2024 - 16:15:00
Bid
02/28/2024 - 16:00:00
Bid
Volume
Ask
02/28/2024 - 16:00:00
Ask
Volume
256.73
+3.78 ( +1.49% )
256.75
3,800
256.88
2,300
More information
Analysis by TheScreener
27.02.2024
Evaluation Slightly negative  
Interest Strong  
Sensibility High  
Analysis date: 27.02.2024
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 15.12.2023.
Interest
  Strong
Strong interest since 13.02.2024.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 29.12.2023 at a price of 236.40.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 26.01.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 222.488.
4wk Rel Perf
  9.59%
 
The four week relative overperformance versus SP500 is 9.59%.
Sensibility
  High
The stock has been on the high-sensitivity level since 15.12.2023.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 0.77%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.63%.
Mkt Cap in $bn
  12.81
With a market capitalization >$8bn, CHARLES RIVER LAB is considered a large-cap stock.
G/PE Ratio
  0.78
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  17.96
The estimated PE is for the year 2026.
LT Growth
  13.95%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  157
For 1% of index variation, the stock varies on average by 1.57%.
Correlation
  0.61
61.11% of stock movements are explained by index variations.
Value at Risk
  103.86
The value at risk is estimated at USD 103.86. The risk is therefore 41.06%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  31.03.2004